CClinicalTrials.gg
Status unknownNCT03171532Updated May 31, 2017

Clinical and Functional Outcomes at 2 Years of 4-strand Versus 5-strand Hamstring Autograft in Anterior Cruciate Ligament Reconstruction

An interventional study of Strands of Hamstring Autograft in ACL reconstruction in Physical Activity, sponsored by National University Hospital, Singapore. Status unknown at 1 site in Singapore. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-31.

Sponsored by National University Hospital, Singapore · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2017), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Dec 2015, registered Feb 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to study differences in clinical and functional outcomes at 2 years based on hamstring graft size after single bundle anatomic ACL reconstruction using either 4-strand or 5-strand hamstring grafts. We also propose to study the characteristics of hamstring graft in our subset of patients in Asian population context.

Read the detailed description

This will be a prospective, randomized interventional study conducted at the National University Hospital under University Orthopaedics and Hand surgery Cluster during the period of December 2015 to December 2018. Study participants: The study will include 80 patients with complete Anterior Cruciate Ligament (ACL) tear undergoing primary arthroscopic reconstruction with ipsilateral hamstring autograft after written informed consent to participate in the study.

The subjects will be divided into two groups A) 4-strand hamstring or B) 5-strand hamstring group by block randomization using an online randomization generator (http://www.graphpad.com/quickcalcs). All the subjects will undergo the procedure by otherwise identical technique performed by single surgeon. At 1 and 2 years functional and subjective outcomes will be assessed.

02

Conditions studied

  • Physical Activity

Keywords

  • ACL
03

In context

Lead sponsor

National University Hospital, Singapore is the lead sponsor of 444 studies on the registry; 96 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age above 18 years
  2. Clinical and MRI confirmed complete ACL tear
  3. Ipsilateral hamstring autograft
  4. Concomitant meniscus injury requiring either meniscus repair or partial menisectomy
  5. Concomitant chondral injury Grade 0,1,2 (International Cartilage Repair Society)
  6. Regular scheduled follow up with adherence to prescribed rehab protocol

Exclusion criteria

Exclusion Criteria:

  1. Non consent
  2. Paediatric patient; age less than 18 years
  3. Partial or incomplete ACL tear
  4. Revision ACL surgery
  5. Hamstring allograft
  6. Multi-ligament injury of the knee (ACL and/or Posterior Cruciate Ligament, Medial Collateral Ligament, Lateral Collateral Ligament, Postero Lateral Corner)
  7. Past history of knee surgery
  8. Contra-lateral ACL injury or other ligament injury
  9. Chondral injury Grade 3,4 (International Cartilage Repair Society)
  10. Intra-articular fracture (past or current)
  11. Radiologically evident osteoarthritis changes
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    4 strand hamstring ACL reconstruction

    The hamstring tendons will be harvested by standard technique and the lengths of the Semitendinosus and Gracilis tendons will be measured after clearing all adherent muscle tissue. The ends will be prepared and folded in middle to prepare4-strand graft.

    Procedure: Strands of Hamstring Autograft in ACL reconstruction

  • Active comparator
    5 strand hamstring ACL reconstruction

    The hamstring tendons will be harvested by standard technique and the lengths of the Semitendinosus (ST) and Gracilis (GR) tendons will be measured after clearing all adherent muscle tissue. For 5-strand graft, minimum length of ST and GR in consideration would be 24 cm and 16 cm respectively. For 5-strand group the ST tendon will be be folded twice and sutured on itself to make a three strand graft and then GR tendon will be folded once along with it to make a final 5-strand graft.

    Procedure: Strands of Hamstring Autograft in ACL reconstruction

Interventions

  • ProcedureStrands of Hamstring Autograft in ACL reconstruction

    The femoral and tibial ends will be tubularised and the final graft diameter will be recorded after passing through sizing cylinders graduated in 0.5mm increments. The femoral and tibial tunnels will be drilled as per standard technique for single bundle ACL reconstruction via trans-portal or trans-tibial route and both ends fixed by interference screw with additional post on the tibial end.

06

What researchers measure

Primary outcomes

  1. Knee Injury and Osteoarthritis Outcome Score (KOOS) Sport/Rec Score (Function in Sport and Recreation) change from baseline

    Patient reported outcome

    Time frame: Baseline, 1 year and 2 years post op

Secondary outcomes

  1. Tegner-Lysholm Score change from baseline

    Patient reported outcome

    Time frame: Baseline, 1 year and 2 years post op

  2. International Knee Documentation Committee (IKDC) Grade change from baseline

    Patient reported outcome

    Time frame: Baseline, 1 year and 2 years post op

  3. KOOS Pain change from baseline

    Patient reported outcome

    Time frame: Baseline, 1 year and 2 years post op

  4. KOOS Symptoms change from baseline

    Patient reported outcome

    Time frame: Baseline, 1 year and 2 years post op

  5. KOOS Function in daily living (KOOS ADL) change from baseline

    Patient reported outcome

    Time frame: Baseline, 1 year and 2 years post op

  6. KOOS Knee-related Quality of Life (KOOS QOL) change from baseline

    Patient reported outcome

    Time frame: Baseline, 1 year and 2 years post op

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 31, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03171532
Lead sponsor
National University Hospital, Singapore
Responsible party
Sponsor
First posted
May 31, 2017
Start date
Dec 1, 2015
Primary completion
Dec 1, 2018 (estimated)
Completion
Dec 31, 2018 (estimated)
Last update
May 31, 2017

Study contacts

Lingaraj Krishna, FRCS (Orth)
Contact
lingaraj_krishna@nuhs.edu.sg
+6567795555
Amritpal Singh, MBBS
Contact
amritpal_singh@nuhs.edu.sg
+6567795555
Lingaraj Krishna, FRCS (Orth)
principal investigator · National University Health System

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion